Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer
详细信息 查看全文
- 作者：Stefan S. Jeppesena ; d ; stefan.jeppesen@rsyd.dk" class="auth_mail" title="E-mail the corresponding author ; Niels-Chr. G. Hansenb ; nc.hansen@dadlnet.dk" class="auth_mail" title="E-mail the corresponding author ; Tine Schyttea ; tine.schytte@rsyd.dk" class="auth_mail" title="E-mail the corresponding author ; Morten Nielsenc ; morten.nielsen@rsyd.dk" class="auth_mail" title="E-mail the corresponding author ; Olfred Hansena ; d ; olfred.hansen@rsyd.dk" class="auth_mail" title="E-mail the corresponding author
- 关键词：COPD ; chronic obstructive pulmonary disease ; NSCLC ; non-small cell lung cancer ; SBRT ; stereotactic body radiotherapy ; FEV1 ; forced expiratory volume in 1&thinsp ; second ; FVC ; forced vital capacity ; GTV ; gross tumour volume ; PTV ; planning target volume ; CCI ; Charlson comorbidity index ; PSM ; propensity score matching ; HR ; hazard ratio ; CAO ; chronic airways obstruction ; GLI ; global lung function initiative
- 刊名：Lung Cancer
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：100
- 期：Complete
- 页码：90-95
- 全文大小：621 K
文摘
- •
The main reason for inoperability in patients with localized NSCLC is chronic obstructive pulmonary disease (COPD).
- •
Patients with COPD have a high annual mortality rate.
- •
Despite the serious prognosis of COPD, a localized NSCLC diagnosis negatively affects survival in COPD patients.
- •
Stereotactic body radiotherapy should still be considered for COPD patients diagnosed with localized NSCLC.